US-based biotechnology company Rallybio has dosed the first subject in a Phase II trial evaluating RLYB212 as a potential ...

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

Dr P Vijaya attended the International Stroke Conference 2025 in Los Angeles, emphasizing the need for standardized stroke ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with $63.6 billion in annual revenue and an impressive 74% gross profit margin, has announced the U.S. Food and Drug Administration's ...

Genitourinary (GU) Cancers Symposium 2025, to be held in San Francisco, USA, from Feb. 13-15, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd ?"Kelun-Biotech" will present efficacy and ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Pain MD, which once ran as many as 20 clinics across three states, gave chronic-pain patients about 700,000 total injections ...

Joint Pain Injections Market Research Report In 2021, the joint pain injections market was valued at approximately $6.27 billion and is pro ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Blood clots form in response to signals from the lungs of cancer patients - not from other organ sites, as previously thought - according to a ...